IP Verse

Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist

Patent No. EP3703818 (titled "Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist") was filed by Regeneron Pharmaceuticals on Oct 29, 2018. The application was issued on Nov 1, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (8)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
DR H ULRICH DORRIESAug 1, 2024DORRIES
DR H ULRICH DORRIESAug 1, 2024DORRIES, HANS ULRICH , DF-MP DORRIES FRANK-MOLNIA & POHLMAN
LUIGIAug 1, 2024TER MEER STEINMEISTER & PARTNER
MICHALSKI HUTTERAMNN & PARTNER PATENTANWALTE MBBAug 1, 2024-
HAMPTON KNOWLESJul 31, 2024D YOUNG
BOEHMERT & BOEHMERT ANWALTSPARTNERSCHAFT MBBJul 30, 2024ENGELHARD
BOULT WADE TENNANTJul 30, 2024BOULT WADE TENNANT
LANYON OPPOSITIONSJul 30, 2024PINSENT MASONS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3703818

REGENERON PHARMACEUTICALS
Application Number
EP18799655A
Filing Date
Oct 29, 2018
Status
Granted And Under Opposition
Sep 29, 2023
Publication Date
Nov 1, 2023
External Links
Slate, Register , Google Patents